Literature DB >> 22133066

Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.

Ying-Yong Zhao1, Xian-Long Cheng, Feng Wei, Xin-Yue Xiao, Wen-Ji Sun, Yongmin Zhang, Rui-Chao Lin.   

Abstract

An ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC Q-TOF MS) metabonomics approach was employed to study the serum metabolic profiling of adenine-induced chronic renal failure (CRF) rats. Acquired data were subjected to principal component analysis (PCA) for differentiating the CRF and the normal control groups. Potential biomarkers were screened by using S-plot and were identified by the accurate mass, isotopic pattern and MS/MS fragments information obtained from UPLC Q-TOF MS analysis. Significant differences in the serum level of creatinine, amino acids and LysoPCs were observed, indicating the perturbations of amino acid metabolism and phospholipid metabolism in adenine-induced CRF rats. This research proved that metabonomics is a promising tool for disease research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133066     DOI: 10.3109/1354750X.2011.637180

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  28 in total

1.  Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.

Authors:  Ya-Long Feng; Gang Cao; Dan-Qian Chen; Nosratola D Vaziri; Lin Chen; Jun Zhang; Ming Wang; Yan Guo; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2019-05-30       Impact factor: 9.261

Review 2.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

3.  Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease.

Authors:  Yan-Ni Wang; Zhi-Hao Zhang; Hong-Jiao Liu; Zhi-Yuan Guo; Liang Zou; Ya-Mei Zhang; Ying-Yong Zhao
Journal:  Acta Pharmacol Sin       Date:  2022-08-03       Impact factor: 7.169

4.  Metabolite identification of ursolic acid in mouse plasma and urine after oral administration by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Authors:  Xueyan Hu; Yunbing Shen; Shengnan Yang; Wei Lei; Cheng Luo; Yuanyuan Hou; Gang Bai
Journal:  RSC Adv       Date:  2018-02-08       Impact factor: 4.036

5.  Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Authors:  Hua Miao; Gang Cao; Xia-Qing Wu; Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Nosratola D Vaziri; Ya-Long Feng; Wei Su; Yi Gao; Shougang Zhuang; Xiao-Yong Yu; Li Zhang; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

6.  A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMS.

Authors:  Ying-Yong Zhao; Hua Chen; Ting Tian; Dan-Qian Chen; Xu Bai; Feng Wei
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

7.  1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.

Authors:  Jin Pyeong Jeon; Taeho Yun; Xing Jin; Won-Sang Cho; Young-Je Son; Jae Seung Bang; Hyun-Seung Kang; Chang Wan Oh; Jeong Eun Kim; Sunghyouk Park
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism.

Authors:  Ying-Yong Zhao; Ya-Long Feng; Xu Bai; Xiao-Jie Tan; Rui-Chao Lin; Qibing Mei
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis.

Authors:  Zhi-Hao Zhang; Feng Wei; Nosratola D Vaziri; Xian-Long Cheng; Xu Bai; Rui-Chao Lin; Ying-Yong Zhao
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.

Authors:  Hua Chen; Gang Cao; Dan-Qian Chen; Ming Wang; Nosratola D Vaziri; Zhi-Hao Zhang; Jia-Rong Mao; Xu Bai; Ying-Yong Zhao
Journal:  Redox Biol       Date:  2016-09-28       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.